Follow us on social media for our latest updates. A book about the corona virus – just for kids! 22/04/2020 What is the coronavirus and how does it make us sick? How can we make sure we don’t get the virus? Why do we have to stay home, and when will everything be normal again? These questions are on all of our minds, including those of children. A weird little virus from bats has us all staying at home. Adrian Liston wrote a children's book about the Corona virus and how we can defeat it. EU-LIFE statement in support of the ERC Scientific Council 10/04/2020 On the resignation of Mauro Ferrari as President of the European Research Council (ERC), EU-LIFE would like to express its public support to the ERC Scientific Council in its decision and declaration. Why chaperones favor basic residues 03/04/2020 Chaperones are essential for proper protein folding. Understanding the biological principles of chaperone-protein binding can help prevent toxic protein aggregation, which occurs in a wide range of disorders. A Leuven research team now shows how the preference of chaperones for basic residues came about. Battle Robots of the Blood 23/03/2020 Adrian Liston teamed up with illustrator Sonia Agüera-Gonzalez to tell the story of Tim, a regular 7-year-old boy, who happens to have a primary immunodeficiency. Alzheimer risk genes converge on microglia 18/03/2020 Our DNA determines a large part of our risk for Alzheimer’s disease, but it remained unclear how many genetic risk factors contribute to disease. A team led by Prof. Bart De Strooper (VIB-KU Leuven) and Dr. Mark Fiers now show that many of those risk factors affect brain maintenance cells called microglia, and more particularly their response to amyloid-beta, one of the proteins aggregating in the brains of Alzheimer patients. A neuroscientist in Hollywood 17/03/2020 Meet Van Den Bosch lab alumna Kim Staats. The Optimist, March 2020 16/03/2020 A new edition of The Optimist is out! The central theme is mental health. VIB and KU Leuven announce new spin-off Augustine Therapeutics to fight neuromuscular diseases 16/12/2019 Today, VIB and KU Leuven present a new venture, Augustine Therapeutics, with the mission to develop innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. Augustine raises a seed-round of 4.2 million euro with V-Bio Ventures, PMV, Advent France Biotechnology, Gemma Frisius Fund and VIB. Local players and great supporters 13/12/2019 While big international funding initiatives might be the most eye-catching science funding sources, local foundations often play an equally pivotal role. They are often more in touch with the local scientific landscape and patients. VIB research would not be where it is now without their support. Here you can find a small sample of generous givers and their interactions with VIB researchers. Snapshot of our foundational funding 13/12/2019 Funding for scientific research is not easy to come by. At the same time, many foundations generously pledge significant amounts to scientists and research programs they believe can further their cause. Below is a snapshot of foundational funding for VIB research. Pagination Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next ›
A book about the corona virus – just for kids! 22/04/2020 What is the coronavirus and how does it make us sick? How can we make sure we don’t get the virus? Why do we have to stay home, and when will everything be normal again? These questions are on all of our minds, including those of children. A weird little virus from bats has us all staying at home. Adrian Liston wrote a children's book about the Corona virus and how we can defeat it.
EU-LIFE statement in support of the ERC Scientific Council 10/04/2020 On the resignation of Mauro Ferrari as President of the European Research Council (ERC), EU-LIFE would like to express its public support to the ERC Scientific Council in its decision and declaration.
Why chaperones favor basic residues 03/04/2020 Chaperones are essential for proper protein folding. Understanding the biological principles of chaperone-protein binding can help prevent toxic protein aggregation, which occurs in a wide range of disorders. A Leuven research team now shows how the preference of chaperones for basic residues came about.
Battle Robots of the Blood 23/03/2020 Adrian Liston teamed up with illustrator Sonia Agüera-Gonzalez to tell the story of Tim, a regular 7-year-old boy, who happens to have a primary immunodeficiency.
Alzheimer risk genes converge on microglia 18/03/2020 Our DNA determines a large part of our risk for Alzheimer’s disease, but it remained unclear how many genetic risk factors contribute to disease. A team led by Prof. Bart De Strooper (VIB-KU Leuven) and Dr. Mark Fiers now show that many of those risk factors affect brain maintenance cells called microglia, and more particularly their response to amyloid-beta, one of the proteins aggregating in the brains of Alzheimer patients.
The Optimist, March 2020 16/03/2020 A new edition of The Optimist is out! The central theme is mental health.
VIB and KU Leuven announce new spin-off Augustine Therapeutics to fight neuromuscular diseases 16/12/2019 Today, VIB and KU Leuven present a new venture, Augustine Therapeutics, with the mission to develop innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. Augustine raises a seed-round of 4.2 million euro with V-Bio Ventures, PMV, Advent France Biotechnology, Gemma Frisius Fund and VIB.
Local players and great supporters 13/12/2019 While big international funding initiatives might be the most eye-catching science funding sources, local foundations often play an equally pivotal role. They are often more in touch with the local scientific landscape and patients. VIB research would not be where it is now without their support. Here you can find a small sample of generous givers and their interactions with VIB researchers.
Snapshot of our foundational funding 13/12/2019 Funding for scientific research is not easy to come by. At the same time, many foundations generously pledge significant amounts to scientists and research programs they believe can further their cause. Below is a snapshot of foundational funding for VIB research.
